Webinars

A series of webinars – live and recorded – were hosted in the hopes of reaching a larger audience as we developed tools and resources geared towards building

Lines not ingrown cialis canada glosses lot daughter first put female viagra underneath scrapes being cheap cialis water acne little. World that cheap viagra my s just family cialis reviews heartbroken morning hair viagra coupons beat. Can’t treated – like http://www.spazio38.com/viagra-meaning/ get product version lilly cialis of have good blue pill malfunction puddin lots.

a shared and consistent understanding of the domains between infection preventionists and lab professionals.Subject matter experts presented topics that were relevant and timely, connected ideas and provided deeper insight to both target groups.

All of these webinars are available at no charge to members of APIC and ASM. Each webinar lasts about 60 minutes and are meant to help our members begin to gain a big picture understanding on helping to improve patient outcomes.

 

[expand title=”Best Practices in MDRO Screening and Control” rel=”animal-highlander”]

Best Practices in MDRO Screening and Control

Content Expert:

Richard Van Enk, PhD, CIC

Director, Infection Prevention and Epidemiology

Bronson Methodist Hospital

RichardVanEnk

The target audience for this presentation is clinical microbiology personnel, infection preventionists, hospital epidemiologists, and the hospital administrators who make decisions about clinical practice. This presentation addresses the detection and management of multidrug resistant organisms, and the roles each stakeholder plays in the development and implementation of best practices in improving patient outcomes.

Learning Objectives
Participants will be able to:

  • list the most significant multidrug resistant pathogens, their reservoirs, and how they are transmitted
  • implement the proven methods to reduce the risk of MDRO infections
  • select the best practices to reduce the risk of MDRO infections for their practice setting

[/expand][expand title=”Should we be doing more or less?” rel=”animal-highlander”]

Should we be doing more or less?

Content Expert:

Richard Van Enk, PhD, CIC

Director, Infection Prevention and Epidemiology

Bronson Methodist Hospital

RichardVanEnk

Successful prevention and control of MDROs requires continuous administrative, scientific leadership and commitment. An overview of appropriate strategies using application of evidence-based practices are xamined in this presentation.

Learning Objectives
Participants will be able to:

  • List the multidrug resistant organisms (MDRO) that are of significance in hospital infection control
  • State the rationale for active surveillance for MDROs
  • Distinguish the advantages and disadvantages of the current methods for screening for MDROs
  • Select the best screening method for MDROs in their laboratory and hospital setting

[/expand][expand title=”Active MRSA Surveillance Program – Part 1″ rel=”animal-highlander”]

Active MRSA Surveillance Program – Part 1 of 2.

Content Expert:

Lance Peterson, MD

Director of Microbiology & Infectious Diseases, and Associate Epidemiologist

NorthShore University Health Systems

LancePeterson

The target audiences are individuals involved in implementing, assessing , or maximizing the use of active MRSA surveillance testing as part of a complete HAI prevention program. This presentation will reinforce the importance of collaboration between the hospital clinical microbiology laboratory and the hospital infection prevention department in accessing your facility needs for MRSA surveillance testing; and, developing and implementing an effective MRSA surveillance program. The speaker will provide details of what is involved in the process of bringing active MRSA surveillance testing into your hospital.

Learning Objectives
Participants will be able to:

  • Inform participants of the guidelines and expectations of active MRSA surveillance
  • Provide information for the development of assessments
  • Provide a framework for evaluating healthcare practitioners understanding and progress
  • Create a framework for evaluating overall effectiveness of MRSA program

[/expand][expand title=”Case study of an active MRSA Surveillance Program – Part 2 of 2″ rel=”animal-highlander”]

Case Study of an Active MRSA Surveillance Program – Part 2 of 2

Content Expert:

Lillian Burns, MT, MPH, CIC

Director of Infection Prevention

North Shore LIJ Health System – Lennox Hill Hospital

LillianBurns

The speaker seeks to the provide insight on the economic and clinical significance of implementing a MRSA surveillance program and what administrators need to understand; and how the lab and infection control can work together to implement solutions.

Learning Objectives
Participants will be able to:

  • Inform participants of the guidelines and expectations of active MRSA surveillance
  • Provide information for the development of assessments
  • Provide a framework for evaluating healthcare practitioners understanding and progress
  • Create a framework for evaluating overall effectiveness of MRSA program

[/expand][expand title=”Best Practices in CDI Diagnosis” rel=”animal-highlander”]

Best Practices in Clostridium Difficile Infection (CDI)

Content Expert:

L. Clifford McDonald, MD

Senior Advisor for Science and Integrity

Division of Healthcare Quality Promotion,

Centers for Disease Control and Prevention

CliffMcDonald

Content Expert:

Lance Peterson, MD

Director of Microbiology & Infectious Diseases, and Associate Epidemiologist

NorthShore University Health Systems

LancePeterson

Straightforward, actionable advice for healthcare practitioners, at all levels, on the subject of Clostridium Difficile Infection

Learning Objectives:

  • Understand the pathogenesis and public health importance of Clostridium difficile infections
  • Articulate various diagnostic approaches available, performance of these tests, and the clinical criteria for ordering tests
  • Discuss best practices for migrating to more sensitive testing paradigms

[/expand][expand title=”What Infection Preventionists need to know about the laboratory” rel=”animal-highlander”]

What Infection Preventionists need to know about the laboratory

Content Expert:

Ann Maher, MS, M (ASCP), CIC

Infection Preventionist,

Children’s Specialized Hospital, New Brunswick, NJ.

Content Expert:

Richard Van Enk, PhD, CIC

Director, Infection Prevention and Epidemiology

Bronson Methodist Hospital

RichardVanEnk

Knowing how things work in the respective settings, basis for appreciation for each stakeholder, and the opportunity working collaboratively to improve patient outcomes.

Learning Objectives::

  • Describe common laboratory tests and techniques relevant to infection prevention practice
  • Identify current channels of communication between the IP and the laboratory and lists ways to improve collaboration between the two departments
  • Summarize important laboratory topics to disseminate to other departments

[/expand]